|
|
|
|
pmid:
|
Kanazawa T et al. |
Inhibition of cytokinesis by a lipid metabolite, psychosine. |
2000 |
J. Cell Biol. |
pmid:10811833
|
Orvisky E et al. |
Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation. |
2000 |
Pediatr. Res. |
pmid:10926300
|
Bischoff A et al. |
Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. |
2000 |
Br. J. Pharmacol. |
pmid:10952677
|
Bischoff A et al. |
Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. |
2000 |
Br. J. Pharmacol. |
pmid:10952678
|
Bischoff A et al. |
Lysosphingolipid receptor-mediated diuresis and natriuresis in anaesthetized rats. |
2001 |
Br. J. Pharmacol. |
pmid:11309265
|
Sueyoshi N et al. |
Apoptosis of Neuro2a cells induced by lysosphingolipids with naturally occurring stereochemical configurations. |
2001 |
J. Lipid Res. |
pmid:11483620
|
Sprong H et al. |
Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex. |
2001 |
J. Cell Biol. |
pmid:11673476
|
Orvisky E et al. |
Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype. |
2002 |
Mol. Genet. Metab. |
pmid:12208131
|
Jatana M et al. |
Apoptotic positive cells in Krabbe brain and induction of apoptosis in rat C6 glial cells by psychosine. |
2002 |
Neurosci. Lett. |
pmid:12231442
|
Sillence DJ et al. |
Glucosylceramide modulates membrane traffic along the endocytic pathway. |
2002 |
J. Lipid Res. |
pmid:12401882
|
Okamoto R et al. |
Sphingosylphosphorylcholine is upregulated in the stratum corneum of patients with atopic dermatitis. |
2003 |
J. Lipid Res. |
pmid:12518027
|
Park JK et al. |
Myoclonic epilepsy in Gaucher disease: genotype-phenotype insights from a rare patient subgroup. |
2003 |
Pediatr. Res. |
pmid:12595585
|
Ishibashi M et al. |
Abnormal expression of the novel epidermal enzyme, glucosylceramide deacylase, and the accumulation of its enzymatic reaction product, glucosylsphingosine, in the skin of patients with atopic dermatitis. |
2003 |
Lab. Invest. |
pmid:12649340
|
Lloyd-Evans E et al. |
Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. |
2003 |
J. Biol. Chem. |
pmid:12709427
|
Bodennec J et al. |
Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride. |
2003 |
J. Lipid Res. |
pmid:12730305
|
Tayebi N et al. |
Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism? |
2003 |
Mol. Genet. Metab. |
pmid:12809640
|
Lloyd-Evans E et al. |
Lyso-glycosphingolipids mobilize calcium from brain microsomes via multiple mechanisms. |
2003 |
Biochem. J. |
pmid:12917012
|
Schueler UH et al. |
Toxicity of glucosylsphingosine (glucopsychosine) to cultured neuronal cells: a model system for assessing neuronal damage in Gaucher disease type 2 and 3. |
2003 |
Neurobiol. Dis. |
pmid:14678774
|
Deguchi H et al. |
Sphingolipids as bioactive regulators of thrombin generation. |
2004 |
J. Biol. Chem. |
pmid:14722105
|
Mogi C et al. |
Sphingosylphosphorylcholine antagonizes proton-sensing ovarian cancer G-protein-coupled receptor 1 (OGR1)-mediated inositol phosphate production and cAMP accumulation. |
2005 |
J. Pharmacol. Sci. |
pmid:16210776
|
Nozawa M et al. |
Novel procedure for measuring psychosine derivatives by an HPLC method. |
1992 |
J. Neurochem. |
pmid:1629732
|
Imokawa G |
A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. |
2009 |
J. Dermatol. Sci. |
pmid:19443184
|
Sun Y et al. |
Neuronopathic Gaucher disease in the mouse: viable combined selective saposin C deficiency and mutant glucocerebrosidase (V394L) mice with glucosylsphingosine and glucosylceramide accumulation and progressive neurological deficits. |
2010 |
Hum. Mol. Genet. |
pmid:20047948
|
Auray-Blais C et al. |
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? |
2010 |
Clin. Chim. Acta |
pmid:20716442
|
Li YT et al. |
Selective extraction and effective separation of galactosylsphingosine (psychosine) and glucosylsphingosine from other glycosphingolipids in pathological tissue samples. |
2011 |
Neurochem. Res. |
pmid:21136152
|
Xu YH et al. |
Accumulation and distribution of α-synuclein and ubiquitin in the CNS of Gaucher disease mouse models. |
2011 |
Mol. Genet. Metab. |
pmid:21257328
|
Dekker N et al. |
Elevated plasma glucosylsphingosine in Gaucher disease: relation to phenotype, storage cell markers, and therapeutic response. |
2011 |
Blood |
pmid:21868580
|
Sun Y et al. |
Ex vivo and in vivo effects of isofagomine on acid β-glucosidase variants and substrate levels in Gaucher disease. |
2012 |
J. Biol. Chem. |
pmid:22167193
|
Zhang CK et al. |
Genome-wide association study of N370S homozygous Gaucher disease reveals the candidacy of CLN8 gene as a genetic modifier contributing to extreme phenotypic variation. |
2012 |
Am. J. Hematol. |
pmid:22388998
|
Cabrera-Salazar MA et al. |
Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease. |
2012 |
PLoS ONE |
pmid:22912851
|
Sardi SP et al. |
Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23297226
|
Sun Y et al. |
Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease. |
2013 |
PLoS ONE |
pmid:23520473
|
Pavlova EV et al. |
B cell lymphoma and myeloma in murine Gaucher's disease. |
2013 |
J. Pathol. |
pmid:23775597
|
Gaspar P et al. |
Action myoclonus-renal failure syndrome: diagnostic applications of activity-based probes and lipid analysis. |
2014 |
J. Lipid Res. |
pmid:24212238
|
Rolfs A et al. |
Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients. |
2013 |
PLoS ONE |
pmid:24278166
|
Angka L et al. |
Glucopsychosine increases cytosolic calcium to induce calpain-mediated apoptosis of acute myeloid leukemia cells. |
2014 |
Cancer Lett. |
pmid:24631520
|
Aflaki E et al. |
Macrophage models of Gaucher disease for evaluating disease pathogenesis and candidate drugs. |
2014 |
Sci Transl Med |
pmid:24920659
|
Gopalan V et al. |
Kinetic analysis of the interaction of alkyl glycosides with two human beta-glucosidases. |
1989 |
Biochem. J. |
pmid:2508630
|
Burrow TA et al. |
CNS, lung, and lymph node involvement in Gaucher disease type 3 after 11 years of therapy: clinical, histopathologic, and biochemical findings. |
2015 |
Mol. Genet. Metab. |
pmid:25219293
|
Welford RW et al. |
Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. |
2014 |
PLoS ONE |
pmid:25479233
|
Sun Y et al. |
Properties of neurons derived from induced pluripotent stem cells of Gaucher disease type 2 patient fibroblasts: potential role in neuropathology. |
2015 |
PLoS ONE |
pmid:25822147
|
Mirzaian M et al. |
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard. |
2015 |
Blood Cells Mol. Dis. |
pmid:25842368
|
Fuller M et al. |
Rapid, single-phase extraction of glucosylsphingosine from plasma: A universal screening and monitoring tool. |
2015 |
Clin. Chim. Acta |
pmid:26232157
|
Dasgupta N et al. |
Neuronopathic Gaucher disease: dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model. |
2015 |
Hum. Mol. Genet. |
pmid:26420838
|
Gramlich PA et al. |
A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment. |
2016 |
J. Biotechnol. |
pmid:26795355
|
Murugesan V et al. |
Glucosylsphingosine is a key biomarker of Gaucher disease. |
2016 |
Am. J. Hematol. |
pmid:27441734
|
Dai M et al. |
Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease. |
2016 |
PLoS ONE |
pmid:27598339
|
Kang L et al. |
Successful newborn screening for Gaucher disease using fluorometric assay in China. |
2017 |
J. Hum. Genet. |
pmid:28356566
|
Igisu H et al. |
Inhibition of cytochrome c oxidase and hemolysis caused by lysosphingolipids. |
1988 |
Lipids |
pmid:2840545
|